Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX
· Real-Time Price · USD
1.43
-0.02 (-1.38%)
At close: Jun 17, 2025, 3:59 PM
1.43
0.33%
After-hours: Jun 17, 2025, 07:21 PM EDT
-1.38% (1D)
| Bid | 1.4 |
| Market Cap | 61.12M |
| Revenue (ttm) | -52.4M |
| Net Income (ttm) | -127.89M |
| EPS (ttm) | -3.02 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -0.94 |
| Analyst | Buy |
| Ask | 1.46 |
| Volume | 79,617 |
| Avg. Volume (20D) | 284,368 |
| Open | 1.44 |
| Previous Close | 1.45 |
| Day's Range | 1.41 - 1.45 |
| 52-Week Range | 0.89 - 4.29 |
| Beta | 0.83 |
About RPTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RPTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RPTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-55.42%
Repare Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
8 months ago
+0%
Repare Therapeutics shares are trading higher after the company announced it will present its Phase 1 data highlighting Camonsertib in combination with radiotherapy treatment at the ASTRO annual meeting
